-
digital.ahrq.gov/sites/default/files/docs/lesson/09-0031-ef-inpatient-cpoe.pdf
January 01, 2009 - drug interactions, patient allergies to prescribed
medications, medication contraindications, and renal … Guided medication dosing for
inpatients with renal insufficiency.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs026522-schoenthaler-final-report-2023.pdf
January 01, 2023 - Patients were excluded if they (a) refused or were unable to provide informed consent;
(b) had acute renal … failure, end stage renal disease (ESRD) or evidence of dialysis, renal transplantation, or
other
-
digital.ahrq.gov/sites/default/files/docs/page/08-0087-EF.pdf
October 01, 2009 - was added later to provide prescribers with patient-specific
maximum dosing recommendations based on renal … A second CDS function for guided medication dosing for residents with renal
insufficiency was evaluated … Implementing a Computerized Clinical Decision
Support System for Guided Medication Dosing for Patients with Renal … Computerized Clinical Decision Support during Medication Ordering for Long-term
Care Residents with Renal
-
digital.ahrq.gov/sites/default/files/docs/lesson/08-0087-ef-lt-care.pdf
October 01, 2009 - added later to provide prescribers with patient-specific
maximum dosing recommendations based on renal … A second CDS function for guided medication dosing for residents with renal
insufficiency was evaluated … Implementing a Computerized Clinical Decision
Support System for Guided Medication Dosing for Patients with Renal … Computerized Clinical Decision Support during Medication Ordering for Long-term
Care Residents with Renal
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs021581-goodney-final-report-2015.pdf
January 01, 2015 - carotid revascularization, we found that age over 80, diabetes, congestive heart
failure, COPD, smoking, renal
-
digital.ahrq.gov/health-it-improved-chronic-disease-management
January 01, 2023 - Patients at the project's renal practice took on average 11 different medications.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs024949-yellowlees-final-report-2022.pdf
January 01, 2022 - disorder(s) — and/or
2) patients who have a chronic medical condition such as diabetes, cardiac or renal … chronic medical problems often had unrecognized psychiatric disorders,
especially those with chronic renal
-
digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
January 01, 2017 - reality include but are not limited to (i) the training of health professionals (e.g., percutaneous
renal
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
January 01, 2011 - adjustments need to take into account, adjusting for gestational age,
chronologic age, ideal weight, renal … Well recognized ADEs in these patients include aminoglycoside-induced renal
failure and high frequency … these medications include myelosuppression due to hydroxyurea,
oversedation due to narcotics, and renal
-
digital.ahrq.gov/sites/default/files/docs/citation/r03hs027006-sun-final-report-2023.pdf
January 01, 2023 - 84% 20% Telemetry/medical patients, CHF,
COPD, Neuro, stroke, pneumonia,
asthma, angina, renal … pulmonary disease
Med/Surg 16 14.59 15 3.47 100% 20% General medical patients such as
renal
-
digital.ahrq.gov/sites/default/files/docs/publication/u18hs016970-bates-final-report-2012.pdf
January 01, 2012 - participated in the survey to identify ADEs,
medication allergies, comorbidities, specific lab results (e.g., renal … We measured rates of testing for lipid levels and renal function, levels of blood pressure and lipid … Medical Error: A 60 year old Man with Delayed Care for a Renal Mass: Clinical Crossroads,
Journal of
-
digital.ahrq.gov/sites/default/files/docs/publication/Parisetal_HFES2008.pdf
January 01, 2008 - antibiotics in which pharmacokinetic monitoring is important
like gentamicin, or for patients with renal
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018648-atlas-final-report-2014.pdf
January 01, 2014 - testing options were to monitor treatment efficacy (LDL,
HbA1c) and/or treatment safety (potassium, renal … Monitoring
Rates of follow-‐up laboratory monitoring within 4 weeks of prescription were highest for renal
-
digital.ahrq.gov/sites/default/files/docs/citation/ecare-plan-final-report.pdf
November 01, 2022 - target laboratory and
clinical values (e.g., HbA1C), patient choices (e.g.,
resuscitation preference, renal … Scenario 3: Patricia’s chronic kidney disease has progressed to renal failure, and
her care planning … When a patient is diagnosed with end-stage renal disease, their PCP will start dialysis
education and … Flow with eCare Plan
eCP = electronic care plan; EHR = electronic health record; ESRD = end-stage renal … The
number of comorbidities predicts renal outcomes in patients with stage 3-5 chronic
kidney disease
-
digital.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf
June 01, 2009 - development and initial implementation costs for a CDS targeted to medication prescribing for
adults with renal … Computerized
clinical decision support during medication
ordering for long-term care residents with renal … implementing a
computerized clinical decision support system for
medication dosing for patients with renal
-
digital.ahrq.gov/sites/default/files/docs/lesson/09-0029-ef-cdm.pdf
January 01, 2009 - Southeast Urban
Trial of Decision Support to Improve Diabetes Outcomes Midwest Urban
Web-based Renal
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023694-schiff-final-report-2018.pdf
January 01, 2018 - the time of medication ordering such as patient specific factors that affect
treatment choice (e.g., renal … red) based on the indication, clinical practice guidelines, and patient-specific
factors (allergies, renal
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs020696-ballard-final-report-2013.pdf
January 01, 2013 - Triglycerides 30,626 (89.7) 9,390 (94.9) 5.1 0.894 0.8
(0.7, 0.9)
-0.12
(-0.20,-0.04) 0.002
Renal … 1.57) 1.00 (0.30,1.70) 0.000 0.6412
Triglycerides 1.33 (1.14, 1.54) 0.75 (0.14,1.36) 0.003 0.6324
Renal
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023989-shah-final-report-2019.pdf
January 01, 2019 - chronic organ damage.[4] Vaso-occlusion is responsible for debilitating SCD complications,
including renal
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024124-meguid-final-report-2018.pdf
January 01, 2018 - complications from 18 to 6 by grouping similar complications together
(infectious, pulmonary, cardiovascular, renal … seven outcomes (0.893 for pulmonary, 0.875 for
bleeding/transfusion, 0.871 for cardiac, 0.863 for renal